-
Je něco špatně v tomto záznamu ?
Solitary Fibrous Tumor - Less Common Neoplasms of the Pleural Cavity
S. Vejvodova, V. Spidlen, P. Mukensnabl, G. Krakorova, J. Molacek, J. Vodicka,
Jazyk angličtina Země Japonsko
Typ dokumentu časopisecké články
NLK
Directory of Open Access Journals
od 2011
Free Medical Journals
od 2011
J-STAGE (Japan Science & Technology Information Aggregator, Electronic) - English
od 2011
J-STAGE (Japan Science & Technology Information Aggregator, Electronic) Freely Available Titles - English
od 2011
PubMed Central
od 2015
Europe PubMed Central
od 2015
Open Access Digital Library
od 2011-01-01
Medline Complete (EBSCOhost)
od 2016-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2011
PubMed
28049955
DOI
10.5761/atcs.oa.16-00108
Knihovny.cz E-zdroje
- MeSH
- biopsie dutou jehlou MeSH
- časové faktory MeSH
- dospělí MeSH
- hrudní chirurgie video-asistovaná * škodlivé účinky MeSH
- lidé středního věku MeSH
- lidé MeSH
- lokální recidiva nádoru MeSH
- prediktivní hodnota testů MeSH
- reoperace MeSH
- retrospektivní studie MeSH
- senioři MeSH
- solitární fibrózní nádor pleury mortalita patologie chirurgie MeSH
- torakotomie * škodlivé účinky MeSH
- tumor burden MeSH
- výsledek terapie MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
PURPOSE: solitary fibrous tumors (SFT) represent a heterogeneous group of primary pleural neoplasms with a low incidence rate and of which the biological origin, which consists of mesenchymal cells, is uncertain. METHODS: The authors present herewith a retrospective analysis of 22 patients with SFTs who were diagnosed and surgically treated between the years 2000-2015. The preoperative tumors were successfully verified morphologically by transthoracic core needle biopsy under CT control in 27.3% of patients. Surgical approaches were either posterolateral thoracotomy or videothoracoscopy. The follow-up median was 45 months (range 1-188 months). RESULTS: Twenty tumors were surgically removed radically, two tumors were found to be unresectable due to the considerable tumor size. From histological point of view 81.8% of tumors were SFT with low malignant potential, 18.2% of tumors with high malignant potential. Despite the radical extirpation of the SFT, it relapsed in two patients. CONCLUSION: The gold standard of SFT treatment is radical surgical removal; however, patients at risk of recurrence require additional follow-ups. The results of adjuvant therapy in recurrent and malignant forms of SFTs are the subject of discussion and further study.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17013320
- 003
- CZ-PrNML
- 005
- 20170428100007.0
- 007
- ta
- 008
- 170413s2017 ja f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.5761/atcs.oa.16-00108 $2 doi
- 035 __
- $a (PubMed)28049955
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ja
- 100 1_
- $a Vejvodova, Sarka $u Clinic of Surgery, Faculty of Medicine in Pilsen, Charles University in Prague, University Hospital Pilsen, Pilsen, Czech Republic.
- 245 10
- $a Solitary Fibrous Tumor - Less Common Neoplasms of the Pleural Cavity / $c S. Vejvodova, V. Spidlen, P. Mukensnabl, G. Krakorova, J. Molacek, J. Vodicka,
- 520 9_
- $a PURPOSE: solitary fibrous tumors (SFT) represent a heterogeneous group of primary pleural neoplasms with a low incidence rate and of which the biological origin, which consists of mesenchymal cells, is uncertain. METHODS: The authors present herewith a retrospective analysis of 22 patients with SFTs who were diagnosed and surgically treated between the years 2000-2015. The preoperative tumors were successfully verified morphologically by transthoracic core needle biopsy under CT control in 27.3% of patients. Surgical approaches were either posterolateral thoracotomy or videothoracoscopy. The follow-up median was 45 months (range 1-188 months). RESULTS: Twenty tumors were surgically removed radically, two tumors were found to be unresectable due to the considerable tumor size. From histological point of view 81.8% of tumors were SFT with low malignant potential, 18.2% of tumors with high malignant potential. Despite the radical extirpation of the SFT, it relapsed in two patients. CONCLUSION: The gold standard of SFT treatment is radical surgical removal; however, patients at risk of recurrence require additional follow-ups. The results of adjuvant therapy in recurrent and malignant forms of SFTs are the subject of discussion and further study.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a biopsie dutou jehlou $7 D062005
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a lokální recidiva nádoru $7 D009364
- 650 _2
- $a prediktivní hodnota testů $7 D011237
- 650 _2
- $a reoperace $7 D012086
- 650 _2
- $a retrospektivní studie $7 D012189
- 650 _2
- $a solitární fibrózní nádor pleury $x mortalita $x patologie $x chirurgie $7 D054363
- 650 12
- $a hrudní chirurgie video-asistovaná $x škodlivé účinky $7 D020775
- 650 12
- $a torakotomie $x škodlivé účinky $7 D013908
- 650 _2
- $a časové faktory $7 D013997
- 650 _2
- $a výsledek terapie $7 D016896
- 650 _2
- $a tumor burden $7 D047368
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Spidlen, Vladimir
- 700 1_
- $a Mukensnabl, Petr
- 700 1_
- $a Krakorova, Gabriela
- 700 1_
- $a Molacek, Jiri
- 700 1_
- $a Vodicka, Josef
- 773 0_
- $w MED00172571 $t Annals of thoracic and cardiovascular surgery official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia $x 2186-1005 $g Roč. 23, č. 1 (2017), s. 12-18
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/28049955 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20170413 $b ABA008
- 991 __
- $a 20170428100329 $b ABA008
- 999 __
- $a ok $b bmc $g 1199785 $s 974098
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 23 $c 1 $d 12-18 $e 20161228 $i 2186-1005 $m Annals of thoracic and cardiovascular surgery $n Ann. thorac. cardiovasc. surg. $x MED00172571
- LZP __
- $a Pubmed-20170413